These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 11104500)

  • 1. Insight into the pathophysiology of restless legs syndrome.
    Earley CJ; Allen RP; Beard JL; Connor JR
    J Neurosci Res; 2000 Dec; 62(5):623-8. PubMed ID: 11104500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered brain iron homeostasis and dopaminergic function in Restless Legs Syndrome (Willis-Ekbom Disease).
    Earley CJ; Connor J; Garcia-Borreguero D; Jenner P; Winkelman J; Zee PC; Allen R
    Sleep Med; 2014 Nov; 15(11):1288-301. PubMed ID: 25201131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restless legs syndrome: update on pathogenesis.
    Dauvilliers Y; Winkelmann J
    Curr Opin Pulm Med; 2013 Nov; 19(6):594-600. PubMed ID: 24048084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of iron in restless legs syndrome.
    Allen RP; Earley CJ
    Mov Disord; 2007; 22 Suppl 18():S440-8. PubMed ID: 17566122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathophysiology of restless legs syndrome].
    Miyamoto M; Miyamoto T; Iwanami M; Suzuki K; Hirata K
    Brain Nerve; 2009 May; 61(5):523-32. PubMed ID: 19514512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine receptors as markers of brain iron deficiency: Implications for Restless Legs Syndrome.
    Quiroz C; Gulyani S; Ruiqian W; Bonaventura J; Cutler R; Pearson V; Allen RP; Earley CJ; Mattson MP; Ferré S
    Neuropharmacology; 2016 Dec; 111():160-168. PubMed ID: 27600688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperactivity, dopaminergic abnormalities, iron deficiency and anemia in an in vivo opioid receptors knockout mouse: Implications for the restless legs syndrome.
    Lyu S; DeAndrade MP; Mueller S; Oksche A; Walters AS; Li Y
    Behav Brain Res; 2019 Nov; 374():112123. PubMed ID: 31376441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine and iron in the pathophysiology of restless legs syndrome (RLS).
    Allen R
    Sleep Med; 2004 Jul; 5(4):385-91. PubMed ID: 15222997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron and restless legs syndrome: treatment, genetics and pathophysiology.
    Connor JR; Patton SM; Oexle K; Allen RP
    Sleep Med; 2017 Mar; 31():61-70. PubMed ID: 28057495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperdopaminergism in lenticulostriate stroke-related restless legs syndrome: an imaging study.
    Ruppert E; Bataillard M; Namer IJ; Tatu L; Hacquard A; Hugueny L; Hubbard J; Kilic-Huck U; Wolff V; Bourgin P
    Sleep Med; 2017 Feb; 30():136-138. PubMed ID: 28215236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron, dopamine, genetics, and hormones in the pathophysiology of restless legs syndrome.
    Khan FH; Ahlberg CD; Chow CA; Shah DR; Koo BB
    J Neurol; 2017 Aug; 264(8):1634-1641. PubMed ID: 28236139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The restless legs syndrome.
    Barrière G; Cazalets JR; Bioulac B; Tison F; Ghorayeb I
    Prog Neurobiol; 2005 Oct; 77(3):139-65. PubMed ID: 16300874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restless legs syndrome: pathophysiology and the role of iron and folate.
    Patrick LR
    Altern Med Rev; 2007 Jun; 12(2):101-12. PubMed ID: 17604457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain iron accumulation in a blood donor family with restless legs syndrome.
    Lillo-Triguero L; Del Castillo A; Guzman de Villoria J; Moran-Jimenez MJ; Guillem A; Peraita-Adrados R
    Rev Neurol; 2019 Feb; 68(3):107-110. PubMed ID: 30687917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attention-deficit/hyperactivity disorder, Tourette's syndrome, and restless legs syndrome: the iron hypothesis.
    Cortese S; Lecendreux M; Bernardina BD; Mouren MC; Sbarbati A; Konofal E
    Med Hypotheses; 2008; 70(6):1128-32. PubMed ID: 18164140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome.
    Connor JR; Wang XS; Allen RP; Beard JL; Wiesinger JA; Felt BT; Earley CJ
    Brain; 2009 Sep; 132(Pt 9):2403-12. PubMed ID: 19467991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI-determined regional brain iron concentrations in early- and late-onset restless legs syndrome.
    Earley CJ; B Barker P; Horská A; Allen RP
    Sleep Med; 2006 Aug; 7(5):458-61. PubMed ID: 16740411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In search of alternatives to dopaminergic ligands for the treatment of restless legs syndrome: iron, glutamate, and adenosine.
    Ferré S; Earley C; Gulyani S; Garcia-Borreguero D
    Sleep Med; 2017 Mar; 31():86-92. PubMed ID: 27899234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 99mTc-TRODAT-1 SPECT as a Potential Neuroimaging Biomarker in Patients With Restless Legs Syndrome.
    Lin CC; Fan YM; Lin GY; Yang FC; Cheng CA; Lu KC; Lin JC; Lee JT
    Clin Nucl Med; 2016 Jan; 41(1):e14-7. PubMed ID: 26204215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating restless legs syndrome: current pathophysiological concepts and clinical trials.
    Walther BW
    Expert Opin Investig Drugs; 2002 Apr; 11(4):501-14. PubMed ID: 11922859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.